Psychiatrists and neuroscientists are taking a major step toward objective mental health diagnosis by launching a central reference database for the classification and communication of mental health ...

Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...

According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial ...

Mental illness is a significant cause of morbidity and mortality globally, with its burden continually increasing. The World Health Organization emphasizes the urgent need for accessible and scalable ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Head and neck cancer (HNC) remains a significant global healthcare challenge, characterized by persistently high incidence and mortality rates. Despite ...

As multicancer early detection research scales, generating sensitive and reproducible biomarker data across large studies remains a critical challenge. While advances in genomic and proteomic tools ...

Researchers have discovered novel biomarkers that could allow doctors to detect endometriosis in its earliest stages through ...

Many parents have long known the link between lower air temperatures and asthma flare-ups in children who suffer from the disorder. But a lack of clear science behind the link has kept many feeling ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...